Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-06

Clinical Trial Update: The Effects of Fluoxetine and/or DHEA [EARLY_Phase 1]

View source ↗

Summary

This early-phase 1 trial evaluates the effects of fluoxetine and/or DHEA in people with Type 1 Diabetes Mellitus and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DHEA (dehydroepiandrosterone)
  • Fluoxetine (Fluoxetine)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Type 1 Diabetes Mellitus | EARLY_Phase 1 | Status: RECRUITING